SNY Sep 2023 55.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:36PM EDT
| Previous close | 1.6000 |
| Open | 2.0900 |
| Bid | 1.7500 |
| Ask | 2.5000 |
| Strike | 55.00 |
| Expiry date | 2023-09-15 |
| Day's range | 2.0000 - 2.0900 |
| Contract range | N/A |
| Volume | |
| Open interest | 25 |
- Zacks
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Regeneron's (REGN) share price rose after it reported data from a late-stage study showing that treatment with Dupixent led to a 30% decline in chronic obstructive pulmonary disease exacerbations.
- Zacks
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
- Zacks
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data
Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.
© 2023 Yahoo. All rights reserved.
